Showing results (1191-1200 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|January 1, 1990
Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patientsH Lenk, S Tanneberger, N Wiener, et al.
Oncology|November 17, 2012
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patientsCamillo Porta, Chiara Paglino, Ilaria Imarisio, et al.
Oncology|January 25, 2014
Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implicationsAntonio Giovanni Richetta, Valentina Silvestri, Simona Giancristoforo, et al.
Oncology|June 14, 2014
Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancerJung-A Yun, Seok-Hyung Kim, Hye Kyung Hong, et al.
Oncology|June 14, 2014
Vascular soft-tissue sarcomas: a prognostic model from a retrospective single-center studyKyoung Sook Park, Hyo Song Kim, Yong Jin Cho, et al.
Oncology|January 1, 1989
Treatment with Krestin combined with mitomycin C, and effect on immune responseT Fujii, N Sugita, Y Kobayashi, et al.
Oncology|May 24, 2014
Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancerShizuo Machida, Yuji Takei, Chikako Yoshida, et al.
Oncology|June 7, 2014
Clinical impact of the extent of lymph node micrometastasis in undifferentiated-type early gastric cancerTomohiro Lee, Hiroaki Tanaka, Masaichi Ohira, et al.
Oncology|June 14, 2014
The addition of C-reactive protein to validated staging systems improves their prognostic ability in patients with hepatocellular carcinomaAkiyoshi Kinoshita, Hiroshi Onoda, Nami Imai, et al.
Oncology|June 20, 2014
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant gliomaFrederic Mack, Niklas Schäfer, Sied Kebir, et al.
Pageof 526